Factors determining symptoms in heart failure: comparison of fast and slow exercise tests.

D P Lipkin, R Canepa-Anson, M R Stephens, P A Poole-Wilson

Factors determining the symptoms of breathlessness and fatigue in patients with congestive heart failure were investigated by comparing the response to slow and fast exercise. Symptom limited oxygen consumption (maximal); minute ventilation, mean pulmonary capillary wedge pressure; and arterial blood gases, pH, and lactate concentrations were measured during treadmill exercise using a slow protocol in 25 men (age 34-67 years) with congestive heart failure (New York Heart Association class II-III). Ten of these patients were also exercised according to a rapid protocol. Exercise was terminated by fatigue in 23/25 patients after the slow test and by breathlessness in all patients after the rapid test. Exercise capacity (maximal oxygen consumption and exercise duration) was not related to resting or exercise pulmonary capillary wedge pressure or the change in pulmonary capillary wedge pressure during exercise, nor was there any difference in pulmonary capillary wedge pressure at the end of exercise within individuals between the fast and slow tests. Minute ventilation was greater (51 vs 43 1/min), peak exercise lactate concentration higher (3.7 vs 2.2 mmol/l), and the change in pH from the resting state was greater (0.06 vs 0.02) during the rapid test than during the slow test. The sensation of breathlessness in congestive heart failure is not simply related to raised pulmonary capillary wedge pressure, but may in part be due to stimulation of peripheral chemoreceptors in response to metabolic acidosis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Witte, K. K.A., Clark, A. L. (2008). Dyspnoea versus fatigue: Additional prognostic information from symptoms in chronic heart failure?. Eur J Heart Fail 10: 1224-1228 [Abstract] [Full Text]  
• Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442 [Full Text]  
• Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989 [Full Text]  
• Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., Kass, D. A. (2006). Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction. Circulation 114: 2138-2147 [Abstract] [Full Text]  
• Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140 [Full Text]  
• Shah, M. R., Hasselblad, V., Stinnett, S. S., Kramer, J. M., Grossman, S., Gheorghiade, M., Adams, K. F. Jr., Swedberg, K., Califf, R. M., O'Connor, C. M. (2002). Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail 4: 297-304 [Abstract] [Full Text]  
• Task Force for the Diagnosis and Treatment of Chro, , Remme, W. J., Swedberg, K. (2001). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560  
• Cotter, G., Kiowski, W., Kaluski, E., Kobrin, I., Milovanov, O., Marmor, A., Jafari, J., Reisin, L., Krakover, R., Vered, Z., Caspi, A. (2001). Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure. Eur J Heart Fail 3: 457-461 [Abstract] [Full Text]  
• Poole-Wilson, P.A. (2001). Importance of control of fluid volumes in heart failure. Eur Heart J 22: 893-894  
• Clark, A.L., Cleland, J.G.F. (2001). How do you measure exercise capacity in chronic heart failure?. Eur Heart J 22: 627-628  
• Caruana, L., Petrie, M. C., McMurray, J. J., MacFarlane, N. G. (2001). Altered diaphragm position and function in patients with chronic heart failure. Eur J Heart Fail 3: 183-187 [Abstract] [Full Text]  
• (2001). Recommendations for exercise testing in chronic heart faliure patients. Eur Heart J 22: 37-45  
• Nanas, S., Nanas, J., Kassiotis, C., Alexopoulos, G., Samakovli, A., Kanakakis, J., Tsolakis, E., Roussos, C. (1999). Respiratory Muscles Performance Is Related to Oxygen Kinetics During Maximal Exercise and Early Recovery in Patients With Congestive Heart Failure. Circulation 100: 503-508 [Abstract] [Full Text]  
• Puri, S., Dutka, D. P., Baker, B. L., Hughes, J. M. B., Cleland, J. G. F. (1999). Acute Saline Infusion Reduces Alveolar-Capillary Membrane Conductance and Increases Airflow Obstruction in Patients With Left Ventricular Dysfunction. Circulation 99: 1190-1196 [Abstract] [Full Text]  
• Webb-Peploe, K M, Henein, M Y, Coats, A J S, Gibson, D G (1998). Echo derived variables predicting exercise tolerance in patients with dilated and poorly functioning left ventricle. Heart 80: 565-569 [Abstract] [Full Text]  
• Lele, S. S., Thomson, H. L., Seo, H., Belenkie, I., McKenna, W. J., Frenneaux, M. P. (1995). Exercise Capacity in Hypertrophic Cardiomyopathy : Role of Stroke Volume Limitation, Heart Rate, and Diastolic Filling Characteristics. Circulation 92: 2886-2894 [Abstract] [Full Text]  
• Puri, S., Baker, B. L., Dutka, D. P., Oakley, C. M., Hughes, J. M. B., Cleland, J. G. F. (1995). Reduced Alveolar–Capillary Membrane Diffusing Capacity in Chronic Heart Failure : Its Pathophysiological Relevance and Relationship to Exercise Performance. Circulation 91: 2769-2774 [Abstract] [Full Text]  
• Dracup, K., Baker, D. W., Dunbar, S. B., Dacey, R. A., Brooks, N. H., Johnson, J. C., Oken, C., Massie, B. M. (1994). Management of Heart Failure: II. Counseling, Education, and Lifestyle Modifications. JAMA 272: 1442-1446 [Abstract]  
• Myers, J., Froelicher, V. F. (1991). Hemodynamic Determinants of Exercise Capacity in Chronic Heart Failure. ANN INTERN MED 115: 377-386 [Abstract]